AAOpt 2023: Success of getting contact lens dropouts back in daily disposables

News
Article

At the 2023 AAOpt annual meeting, data was presented on the frequency of success of patients struggling with contact lens drop out getting back into daily disposable lenses.

Andrew D. Pucker, OD, PhD, FAAO, FSLS, FBCLA, shared highlights from his poster, "Frequency of Successfully Bringing Contact Lens Dropouts Back into a Modern Daily Disposable Contact Lens at 6-Months," which he presented during the 2023 American Academy of Optometry in New Orleans.

Editor's note: This transcript has been edited for clarity.

Andrew D. Pucker, OD, PhD, FAAO, FSLS, FBCLA:

My name is Andrew Pucker, I'm the Senior Director of Clinical and Medical Sciences at Lexitas Pharma Services. I'm excited to be presenting my poster at Academy this year, which is on understanding how well patients can do with Dailies Total 1 for the first 6 months after being a contact lens drop out.

So, we enrolled subjects who were struggling with contact lenses, they really couldn't wear them anymore. What we wanted to do is see if we could bring them back into wearing lenses. We put everyone, all 60 subjects, into Dailies Total 1. We saw them in-person for a fitting, we [follow-up] in that one month in-person. Then, the focus of my poster has been the 6 month survey data.

What we found was that the vast majority of patients, over 80% of patients, were still wearing Dailies Total 1 at 6 months. [It's] amazing that they were people who are pretty much giving up on contact lenses, and now they're happy, healthy contact lens wearers again. With that, the same patients are happy to recommend these contact lenses to a friend, and they can wear them pretty much all day.

I think one of the big clinical takeaways we need to give to our patients is that if you are a contact lens wearer and struggling, there are options for you. So if you [are] not quite happy, make sure it's known to your doctor. The doctor should be actively asking these questions as well. If you find out that they're struggling, you should just offer them an alternative option, and [a] potentially good one is Dailies Total 1.

What's next for this research? Well, we only have data on Dailies Total 1. What we could potentially do is look at other modern contact lenses. This work was based on work from [Dr] Young [in] around 2002. In that study, they allowed patients to try any contact lens and they found that roughly 75% of patients could resume contact lenses. But, the data we have here is just on one lens and we could expand that to any modern lens and see if other lenses can perform as well.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Nora Lee Cothran, OD, FAAO, discussed the importance of optometrists addressing mental health with patients in their chair.
Devin Sasser, OD, shares his excitement for Acuvue Oasys MAX 1-Day multifocal for astigmatism, the first and only daily disposable multifocal toric contact lens.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Karen R. Hoffman, OD, speaks on her AOA 2025 poster, which details a case series on fitting patients with irregular cornea and astigmatism with Zenlens (Bausch + Lomb)
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
© 2025 MJH Life Sciences

All rights reserved.